Asymchem Laboratories (Tianjin) Co., Ltd.
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | Kailaiying Pharmaceutical Group (Tianjin) Co., Ltd. (stock code: 002821. SZ/6821. HK) is a globally leading CDMO company that provides high-quality one-stop services for research, development, and production of new drugs worldwide. Taking accelerating the launch of new drugs and extending the quality of life as our own responsibility, relying on continuous technological innovation, we provide one-stop CMC services throughout the entire drug lifecycle for domestic and foreign pharmaceutical and biotechnology companies, accelerating the development and application of new drugs. The business scope covers the early clinical stage to the commercialization stage, including the research and development of advanced intermediates, raw materials, formulations, and cGMP production, as well as clinical research services. And through strategic cooperation and business expansion, we will gradually build an integrated service ecosystem for innovative drugs and become partners in global new drug research and production. |
| Headquarter | Tianjin |
| Establish Date | 10/7/1998 |
| Listed Code | 002821.SZ |
| Listed Date | 11/18/2016 |
| Chairman | HAO HONG |
| CEO | HAO HONG |
| Website | www.asymchem.com.cn |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
